Others

Present position: Home » Technology » Others

Measles Vaccine Technology

Product Presentation

Measles is an acute respiratory disease caused by the measles virus. In recent years, with the Expanded Programme on Immunization(EPI) implementation and Children's Vaccine Initiative (CVI) launching, high quality and quantity of measles vaccine have been required. Comprehensive eliminating measles has become new goal in the 21st century.

Freeze dried live measles vaccine in china is asked to do a virus titration and stability test at 37°C for 7 days since 1990s. Double standard significantly increased the difficulty of measles vaccine production. The factor of complexity process, long-cycle and thermal instability led to titers decreased, more losses, as well as more instablity of yield and quality for intermediate products and finished vaccine. Therefore, it is hard to meet the social need.

How to solve the matter of low-qualified, of unstable quality, of high-cost, and reduce vaccine side-effects, improve the yield and quality, which is always the measles vaccine manufactures diligently direction. 

 

Contact for details

Add:    Room 701B/D, Building B, Science Park Tower, Tsinghua Science Park, Haidian District, Beijing 100084, China

Tel:    +86 10 62795180

Fax:    +86 10 62795182

E-mail:  biotech@ittc.com.cn 

Website: www.coway.com.cn    www.coway-biotech.com

Copyright: Coway International TechTrans Co., Ltd.   2012 © Coway All rights reserved. 京ICP备05080655号-4